Olive leaf extract for controlling diabetes
Part of Hormones & metabolism clinical trials.
This trial studies whether olive leaf extract can help control diabetes. If you’re an adult with diabetes, you may be eligible to join and see how this supplement affects your blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You must have a diagnosis of diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking propolis (a bee product) can help lower cholesterol in people with type 2 diabetes. It is for those whose diabetes is well-controlled and who are already on cholesterol medication.
This study tests a drink made from grape pomace (a natural byproduct) that is rich in polyphenols—compounds that may help the liver and heart. Participants have type 2 diabetes and mild fatty liver, and researchers want to see if the drink improves liver health, blood sugar, and gut bacteria over several months.
This study tests whether olive pomace oil, a type of olive oil, can lower blood sugar in people with prediabetes or diabetes. It may be an option if you have high blood sugar and are not taking other medications or supplements.
This study tests whether taking olive leaf extract (a natural supplement) can improve the health of your blood vessels after a heart attack. It may help your arteries function better and support your recovery.
This study tests whether taking olive leaf extract supplements can improve how your muscles respond to exercise training. It involves a training program and taking a daily supplement, and may help you build muscle more effectively.
This study tests whether adding omega-3 supplements to your regular diabetes treatment can improve blood sugar control and cholesterol. It may help people with type 2 diabetes who are already on medication.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.